Dr Melvin Sanicas ✓

@Vaccinologist · Switzerland · joined 19 Jul 2017

Physician-scientist MD, MSc, MBA #FIDSA #FRSPH #FRSA #FAcadMEd #TOYM Science & Medicine '21 #PAFIOO #PresidentialAward '24 Sharing insights on #GlobalHealth

34 775Followers

1 946Following

10 442Posts total

12.4KViews on collected posts

Postingan terbaru

Dr Melvin Sanicas ✓@Vaccinologist16 Sep

#Dengue is continuing to expand beyond its traditional tropical range, with locally acquired transmission increasingly reported in the US, including #Florida. The spread of #Aedesaegypti highlights the combined effects of #climate #urbanization + #travel. https://t.co/sG0BJOd5AZ

855 views · 7 likes · 3 reposts · 0 replies Open on X →

Dr Melvin Sanicas ✓@Vaccinologist15 Sep

New @IcahnMountSinai study shows that a small subset of #pancreaticcancer cells can create fibrin-rich immune-protective niches via PAI1/PAI2, recruiting suppressive macrophages & excluding #Tcells - a new angle for pancreatic #cancer #immunotherapy https://t.co/1mBjoRk2nH https:

350 views · 4 likes · 2 reposts · 0 replies Open on X →

Dr Melvin Sanicas ✓@Vaccinologist15 Sep

Real-world data on #nirsevimab #Beyfortus: 79% effectiveness against #RSV hospitalization, 97% against ICU admission in infants. Severe RSV was seen largely in otherwise healthy babies, supporting broad prevention rather than risk-based targeting alone. https://t.co/WuO5IFZWHY ht

505 views · 6 likes · 1 reposts · 0 replies Open on X →

Dr Melvin Sanicas ✓@Vaccinologist14 Sep

#mpox remains an active and evolving global #publichealth challenge. Transmission is persisting in multiple regions, clade Ib #MPXV is expanding beyond its earlier geographic concentration, Africa continues to bear the greatest burden - latest from @WHO https://t.co/i1TP4uxYA7 ht

319 views · 50 likes · 1 reposts · 0 replies Open on X →

Dr Melvin Sanicas ✓@Vaccinologist10 Aug

Grateful to the @LSHTM for recognizing my election as a Fellow of the @IDSAInfo Infectious Diseases Society of America #FIDSA. I completed my MSc in Infectious Diseases at the #LSHTM so this recognition is especially meaningful. https://t.co/DwkDNmChTC https://t.co/Ns400rzv9n

10.4K views · 64 likes · 1 reposts · 0 replies Open on X →

Dibandingkan akun berukuran sama

5 postingan dari 90 hari terakhir, dibandingkan dengan rentang 10K–100K pengikut. menjangkau lebih sedikit orang dibanding akun seukurannya.

Median tayangan505akun ini972median untuk 10K–100K

Jangkauan, %1.45%akun ini3.58%median untuk 10K–100K

Interaksi, %1.58%akun ini1.60%median untuk 10K–100K

Metrik	Akun ini	Median untuk 10K–100K	Rasio
Median tayangan per postingan	505	972	0.52×
Jangkauan (tayangan ÷ pengikut)	1.45%	3.58%	0.41×
Tingkat interaksi	1.58%	1.60%	0.99×

Akun lain pada rentang ini → Bandingkan dengan akun lain → Bagaimana tolok ukur ini disusun →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

10.4K10 Aug

31914 Sep

50515 Sep

350

85516 Sep

Last 5 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

0.63%10 Aug

16.30%14 Sep

1.58%15 Sep

2.00%

1.29%16 Sep

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.60%.

What the audience does

Likes89.7%131 in total

Reposts5.5%8 in total

Quotes2.7%4 in total

Bookmarks2.1%3 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.